Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

United States AI in Healthcare Market Forecast Report and Company Analysis 2025-2033 Featuring AWS, General Vision, Google, Intel, Medtronic, Micron, Microsoft, Next IT, NVIDIA, Siemens Healthcare

globenewswire.com
AMZN AWS is mentioned as a participant in the US AI in Healthcare market, indicating its involvement but without specific positive or negative commentary. GOOGL Google is listed as a company involved in the US AI in Healthcare market, suggesting its presence and potential role without explicit sentiment. INTC Intel is mentioned as a company within the US AI in Healthcare market forecast, indicating its participation without specific sentiment. MDT Medtronic is featured in the company analysis for the US AI in Healthcare market, suggesting its involvement without explicit sentiment. MU Micron is listed as a company analyzed within the US AI in Healthcare market forecast, indicating its participation without specific sentiment. MSFT Microsoft is mentioned as a company involved in the US AI in Healthcare market, suggesting its presence and potential role without explicit sentiment. NVDA NVIDIA is listed as a key company in the US AI in Healthcare market forecast, indicating its significant presence but without explicit sentiment.

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "United States AI in Healthcare Market Report by Offering, Technology, Application, End User, States and Company Analysis 2025-2033" has been added to ResearchAndMarkets.com's offering.

The United States AI in Healthcare Market is expected to reach US$ 99.77 billion by 2033 from US$ 10.26 billion in 2025, with a CAGR of 32.88% from 2025 to 2033. Rapid digital transformation, growing demand for precision medicine, robust government support, and the need for affordable healthcare solutions are the main factors propelling the U.S. AI in healthcare market. National adoption is further accelerated by expanding healthcare applications and increasing investments in AI innovation.

In order to enhance patient care, diagnosis, and treatment planning, artificial intelligence (AI) in healthcare uses sophisticated algorithms, machine learning, and data analytics. AI gives doctors the ability to rapidly evaluate complicated medical data, providing insights for early disease detection and tailored treatment suggestions. Predictive analytics, drug development, virtual health assistants, and medical imaging are a few examples of applications. AI lowers costs while increasing access to healthcare by automating repetitive tasks and boosting clinical accuracy. AI is emerging as a key instrument for enhancing productivity, patient outcomes, and creativity in medical and administrative operations as American healthcare organizations continue to embrace digital transformation.

The demand for better diagnosis accuracy, the growing use of digital health technology, and developments in machine learning and data integration are driving the growth of the AI in healthcare market in the United States. AI is being used by hospitals and research facilities for customized medicine, predictive analytics, and medical imaging, which improves results and lowers expenses. The FDA's support for AI-based medical devices and government programs encouraging healthcare digitization further accelerate industry growth. The United States is becoming a global leader in healthcare innovation as a result of the acceleration of AI integration brought about by rising healthcare costs and the expansion of big data availability.

Growth Drivers for the United States AI in Healthcare Market

Expanding Integration of AI in Clinical Decision-Making

The integration of AI into clinical decision-making is transforming how healthcare is delivered in the United States. Advanced algorithms support physicians in diagnosing diseases, predicting treatment outcomes, and identifying at-risk patients with greater speed and accuracy. AI-driven systems enhance clinical workflows by processing vast datasets - including imaging scans, lab results, and patient histories - to deliver actionable insights in real time.

In April 2025, Tempus partnered with Illumina to merge AI-driven clinical data with genomic sequencing, strengthening precision medicine and enabling more personalized treatment decisions. This integration of genomic and clinical intelligence represents the next step in AI-driven healthcare. Hospitals and research institutions increasingly rely on AI for decision support, ensuring improved efficiency, reduced diagnostic errors, and optimized care pathways. As AI becomes deeply embedded in healthcare ecosystems, it is redefining evidence-based medicine by transforming data into precise, patient-centered insights that enhance both outcomes and system performance.

Growing Adoption of Personalized and Precision Medicine

The rapid advancement of personalized and precision medicine is a major driver of AI adoption in the U.S. healthcare market. Artificial intelligence enables the analysis of genetic, environmental, and lifestyle data to design individualized treatment plans tailored to each patient's unique profile. By integrating genomic sequencing with machine learning, clinicians can better predict disease risk, select targeted therapies, and monitor treatment efficacy in real time.

AI-powered precision medicine platforms are being deployed across oncology, neurology, and cardiology to identify molecular markers and optimize care delivery. The ongoing digitization of health records and genomic data provides a robust foundation for predictive modeling. As healthcare shifts from reactive to preventive and personalized care, AI tools empower providers to move beyond "one-size-fits-all" approaches. This data-driven, patient-focused model not only improves therapeutic accuracy but also reduces costs and enhances long-term healthcare outcomes across the United States.

Advancements in Natural Language Processing (NLP)

Advancements in Natural Language Processing (NLP) are accelerating AI adoption across the U.S. healthcare sector by transforming how unstructured clinical data is utilized. NLP algorithms can interpret physician notes, medical transcripts, and patient communications to extract valuable insights for diagnosis, treatment, and patient monitoring. These capabilities streamline documentation, enhance care coordination, and improve decision accuracy. Additionally, NLP supports conversational AI tools that assist clinicians with real-time information retrieval and patients with symptom checking or post-care guidance.

In December 2024, California enacted Assembly Bill 3030, requiring providers to disclose when generative AI is used in patient communication - highlighting the growing integration of AI-driven language tools in healthcare. This legislation underscores both the potential and responsibility of NLP technologies. As hospitals and digital health platforms continue deploying AI-enabled communication systems, NLP plays a crucial role in bridging human and machine understanding, improving efficiency, compliance, and patient engagement across the care continuum.

Challenges in the United States AI in Healthcare Market

Data Privacy and Regulatory Compliance

One of the major challenges in the U.S. AI in Healthcare market is ensuring data privacy and compliance with complex regulations such as HIPAA and emerging state-specific laws. AI systems rely on vast amounts of sensitive patient information, creating potential risks of data breaches and unauthorized access. Ensuring transparency and maintaining ethical AI practices are also critical as algorithms increasingly influence medical decisions. Healthcare organizations face difficulties balancing innovation with stringent compliance requirements.

Additionally, the lack of standardized data-sharing protocols limits interoperability between systems, hindering AI's full potential. Strengthening cybersecurity infrastructure, implementing robust consent mechanisms, and developing clear AI governance frameworks are essential to mitigate these challenges.

High Implementation Costs and Skill Gaps

The high cost of implementing AI technologies and the shortage of skilled professionals pose significant barriers to market growth. Integrating AI into healthcare systems requires substantial investment in software, hardware, and staff training. Many small and mid-sized hospitals struggle to afford these technologies, leading to uneven adoption across regions. Moreover, the healthcare workforce faces a steep learning curve in using AI-driven tools effectively, creating a gap between technical innovation and clinical application. Limited collaboration between technology providers and medical practitioners further slows deployment. Addressing these issues through affordable AI solutions, educational programs, and cross-sector partnerships is crucial to ensure equitable access and sustainable growth across the healthcare ecosystem.

Key Attributes:

Key Topics Covered:

1. Introduction

2. Research & Methodology

2.1 Data Source

2.1.1 Primary Sources

2.1.2 Secondary Sources

2.2 Research Approach

2.2.1 Top-Down Approach

2.2.2 Bottom-Up Approach

2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. United States AI In Healthcare Market

5.1 Historical Market Trends

5.2 Market Forecast

6. Market Share Analysis

6.1 By Offering

6.2 By Technology

6.3 By Application

6.4 By End-User

6.5 By States

7. Offering

7.1 Hardware

7.2 Software

7.3 Services

8. Technology

8.1 Machine Learning

8.2 Context Aware Computing

8.3 Natural Language Processing

8.4 Others

9. Application

9.1 Robot-Assisted Surgery

9.2 Virtual Nursing Assistant

9.3 Administrative Workflow Assistance

9.4 Fraud Detection

9.5 Dosage Error Reduction

9.6 Clinical Trial Participant Identifier

9.7 Preliminary Diagnosis

9.8 Others

10. End-User

10.1 Healthcare Providers

10.2 Pharmaceutical and Biotechnology Companies

10.3 Patients

10.4 Others

11. Top States

11.1 California

11.2 Texas

11.3 New York

11.4 Florida

11.5 Illinois

11.6 Pennsylvania

11.7 Ohio

11.8 Georgia

11.9 New Jersey

11.10 Washington

11.11 North Carolina

11.12 Massachusetts

11.13 Virginia

11.14 Michigan

11.15 Maryland

11.16 Colorado

11.17 Tennessee

11.18 Indiana

11.19 Arizona

11.20 Minnesota

11.21 Wisconsin

11.22 Missouri

11.23 Connecticut

11.24 South Carolina

11.25 Oregon

11.26 Louisiana

11.27 Alabama

11.28 Kentucky

11.29 Rest of United States

12. Value Chain Analysis

13. Porter's Five Forces Analysis

13.1 Bargaining Power of Buyers

13.2 Bargaining Power of Suppliers

13.3 Degree of Competition

13.4 Threat of New Entrants

13.5 Threat of Substitutes

14. SWOT Analysis

14.1 Strength

14.2 Weakness

14.3 Opportunity

14.4 Threats

15. Key Players Analysis

15.1 Overviews

15.2 Key Person

15.3 Recent Developments

15.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/dr9rcc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment